Cargando…

Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit

BACKGROUND: As a result of the coronavirus disease 2019 (COVID-19) pandemic, institutions needed innovative solutions to provide care. With implementation of telehealth, a cystic fibrosis (CF) pharmacist was able to incorporate a virtual medication tour during appointments. OBJECTIVE: The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Warda, Nicole, Rotolo, Shannon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Pharmacists Association®. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056476/
https://www.ncbi.nlm.nih.gov/pubmed/33931355
http://dx.doi.org/10.1016/j.japh.2021.04.005
_version_ 1783680654535294976
author Warda, Nicole
Rotolo, Shannon M.
author_facet Warda, Nicole
Rotolo, Shannon M.
author_sort Warda, Nicole
collection PubMed
description BACKGROUND: As a result of the coronavirus disease 2019 (COVID-19) pandemic, institutions needed innovative solutions to provide care. With implementation of telehealth, a cystic fibrosis (CF) pharmacist was able to incorporate a virtual medication tour during appointments. OBJECTIVE: The purpose of our study was to describe the uptake and impact of pharmacist-led virtual medication tours during telehealth visits in the CF clinic setting. PRACTICE DESCRIPTION: Before the COVID-19 pandemic, a CF pharmacist participated in in-person multidisciplinary team visits to complete medication history reconciliation, assess adherence, assess efficacy and address possible adverse effects of medications, and work collaboratively with the CF care team and patient to create therapeutic plans. The virtual medication tour described in this study was completed in addition or as a complement to these pre-existing pharmacist roles and responsibilities. PRACTICE INNOVATION: Patients seen via telehealth visit were asked to provide a virtual tour of their medications. A pharmacist completed medication history and evaluated whether storage conditions were appropriate in regard to temperature, humidity, light exposure, and accessibility to children. EVALUATION METHODS: A pharmacist recorded findings from the virtual medication tours and made interventions when appropriate. Descriptive statistics were used for analysis. RESULTS: Of 20 patients seen via telehealth for a quarterly visit during the first 3 months after implementation, 13 were willing to participate in a virtual medication tour. Before the visit, 25% had information missing from their medication list. Virtual medication tour allowed for resolution of this information 80% of the time. Three of the 4 participating patients with a child under 12 years old had medications stored in a location accessible to children. CONCLUSION: A virtual medication tour led by a pharmacist can be successfully incorporated into telehealth visits and was accepted by a majority of patients. Most patients stored medications appropriately but might benefit from education on poison prevention practices.
format Online
Article
Text
id pubmed-8056476
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Pharmacists Association®. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-80564762021-04-20 Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit Warda, Nicole Rotolo, Shannon M. J Am Pharm Assoc (2003) Science and Practice BACKGROUND: As a result of the coronavirus disease 2019 (COVID-19) pandemic, institutions needed innovative solutions to provide care. With implementation of telehealth, a cystic fibrosis (CF) pharmacist was able to incorporate a virtual medication tour during appointments. OBJECTIVE: The purpose of our study was to describe the uptake and impact of pharmacist-led virtual medication tours during telehealth visits in the CF clinic setting. PRACTICE DESCRIPTION: Before the COVID-19 pandemic, a CF pharmacist participated in in-person multidisciplinary team visits to complete medication history reconciliation, assess adherence, assess efficacy and address possible adverse effects of medications, and work collaboratively with the CF care team and patient to create therapeutic plans. The virtual medication tour described in this study was completed in addition or as a complement to these pre-existing pharmacist roles and responsibilities. PRACTICE INNOVATION: Patients seen via telehealth visit were asked to provide a virtual tour of their medications. A pharmacist completed medication history and evaluated whether storage conditions were appropriate in regard to temperature, humidity, light exposure, and accessibility to children. EVALUATION METHODS: A pharmacist recorded findings from the virtual medication tours and made interventions when appropriate. Descriptive statistics were used for analysis. RESULTS: Of 20 patients seen via telehealth for a quarterly visit during the first 3 months after implementation, 13 were willing to participate in a virtual medication tour. Before the visit, 25% had information missing from their medication list. Virtual medication tour allowed for resolution of this information 80% of the time. Three of the 4 participating patients with a child under 12 years old had medications stored in a location accessible to children. CONCLUSION: A virtual medication tour led by a pharmacist can be successfully incorporated into telehealth visits and was accepted by a majority of patients. Most patients stored medications appropriately but might benefit from education on poison prevention practices. American Pharmacists Association®. Published by Elsevier Inc. 2021 2021-04-20 /pmc/articles/PMC8056476/ /pubmed/33931355 http://dx.doi.org/10.1016/j.japh.2021.04.005 Text en © 2021 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Science and Practice
Warda, Nicole
Rotolo, Shannon M.
Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit
title Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit
title_full Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit
title_fullStr Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit
title_full_unstemmed Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit
title_short Virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit
title_sort virtual medication tours with a pharmacist as part of a cystic fibrosis telehealth visit
topic Science and Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056476/
https://www.ncbi.nlm.nih.gov/pubmed/33931355
http://dx.doi.org/10.1016/j.japh.2021.04.005
work_keys_str_mv AT wardanicole virtualmedicationtourswithapharmacistaspartofacysticfibrosistelehealthvisit
AT rotoloshannonm virtualmedicationtourswithapharmacistaspartofacysticfibrosistelehealthvisit